Baidu
map

全新美国mHealth应用使用调查,96%使用者认可Apps的作用

2015-04-20 一韦 生物谷

近期,Research Now的一项调查显示: 46%的医生表示在未来5年内,他们会推荐患者使用相关医疗健康类应用(以下简称应用); 86%的医生相信应用有助于了解患者的身体状况; 96%的应用的使用者认为这些应用可提高他们的生活质量; 72%的医生相信应用鼓励患者对自己的健康承担更多责任; 此次调查针对美国500位医生和1000名医疗健康类应用的使用




近期,Research Now的一项调查显示:

46%的医生表示在未来5年内,他们会推荐患者使用相关医疗健康类应用(以下简称应用);

86%的医生相信应用有助于了解患者的身体状况;

96%的应用的使用者认为这些应用可提高他们的生活质量;

72%的医生相信应用鼓励患者对自己的健康承担更多责任;

此次调查针对美国500位医生和1000名医疗健康类应用的使用者(以下简称使用者),

从整个调查结果来看,我们可以看到一些新结果:

(1)医生认为应用有助于医疗护理水平的提高

86%的医生相信应用有助于了解患者的身体状况;

72%的医生相信应用鼓励患者对自己的健康承担更多责任;

50%的医生认为应用可以加快对病人的治疗效率;

46%的医生认为应用有助于改善医患关系。

(2)医生认为最大的受益者是慢性病患者

76%的医生认为应用可以帮助慢性病患者,如糖尿病、心血管疾病患者。

61%的医生认为应用可以帮助那些已经有病症的人;55%的人士认为可以帮助到那些自认为健康的人;48%认为他们可能帮助到那些刚刚出院的病人。

(3)多数人表示应用是一种生活方式的选择

多数人是使用应用帮助他们减肥、跟踪他们的健康。其中60%的用于自我监测或锻炼,53%用于激励他们锻炼,49%记录卡路里摄入量,42%的用于减肥。

30%的使用应用去监测他们所居住的环境,29%提醒他们自己吃药。

96% 应用使用者认为应用提高了他们的生活质量,然而只有37%的医疗专业人士认可这点。

(4)只有少数医生在使用此类应用,不过,他们希望在未来的5年内能起来

总体而言,仅有少量移动智能技术应用到了医疗领域。

16%的医生将它们用于患者,46%的医疗专业人士表示在未来5年内,他们会推荐患者使用相关应用。

19%的医生不认为移动智能技术将变成他们医疗领域工作的一部分。

59%的医生利用移动智能技术用于医学研究,28%的期望接下来5年内在专业领域可以使用这些新技术。

32%的应用使用者表示分享了他们通过应用从医生哪里获得信息。

虽然,整个调查在美国展开,但是目前中国医生、医疗健康类应用的使用者而言,是不是面临同样的结果呢?

带着疑问,梅斯医学旗下Bioinsight设计了系列调查,调研时间为期一个月,最终结果将与参与调研者共享,并供广大医生和医疗健康类应用开发者参考。

进入移动医疗APP的健康管理效果调查问卷

http://survey.bioon.com/index.php?sid=86853&lang=zh-Hans


数据来源:


http://mhealthintelligence.com/news/96-percent-of-patients-think-mhealth-will-improve-life

http://www.marketwired.com/press-release/are-mobile-medical-apps-good-our-health-a-new-study-research-now-reveals-that-doctors-2001197.htm#.VQrl_qFHUAc.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1977246, encodeId=4b7719e72465c, content=<a href='/topic/show?id=f37214590b2' target=_blank style='color:#2F92EE;'>#PPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14590, encryptionId=f37214590b2, topicName=PPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Aug 11 13:55:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861007, encodeId=7a53186100eda, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Sep 11 11:55:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621533, encodeId=e2c4162153301, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed Apr 22 07:55:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21463, encodeId=454821463f0, content=很漂亮啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=58.33.140.**, createdTime=Mon Apr 20 21:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21449, encodeId=9ac22144917, content=赞的, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.67.**, createdTime=Mon Apr 20 17:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=)]
    2015-08-11 yyj062
  2. [GetPortalCommentsPageByObjectIdResponse(id=1977246, encodeId=4b7719e72465c, content=<a href='/topic/show?id=f37214590b2' target=_blank style='color:#2F92EE;'>#PPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14590, encryptionId=f37214590b2, topicName=PPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Aug 11 13:55:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861007, encodeId=7a53186100eda, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Sep 11 11:55:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621533, encodeId=e2c4162153301, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed Apr 22 07:55:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21463, encodeId=454821463f0, content=很漂亮啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=58.33.140.**, createdTime=Mon Apr 20 21:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21449, encodeId=9ac22144917, content=赞的, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.67.**, createdTime=Mon Apr 20 17:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=)]
    2015-09-11 shizhenshan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1977246, encodeId=4b7719e72465c, content=<a href='/topic/show?id=f37214590b2' target=_blank style='color:#2F92EE;'>#PPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14590, encryptionId=f37214590b2, topicName=PPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Aug 11 13:55:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861007, encodeId=7a53186100eda, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Sep 11 11:55:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621533, encodeId=e2c4162153301, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed Apr 22 07:55:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21463, encodeId=454821463f0, content=很漂亮啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=58.33.140.**, createdTime=Mon Apr 20 21:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21449, encodeId=9ac22144917, content=赞的, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.67.**, createdTime=Mon Apr 20 17:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1977246, encodeId=4b7719e72465c, content=<a href='/topic/show?id=f37214590b2' target=_blank style='color:#2F92EE;'>#PPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14590, encryptionId=f37214590b2, topicName=PPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Aug 11 13:55:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861007, encodeId=7a53186100eda, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Sep 11 11:55:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621533, encodeId=e2c4162153301, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed Apr 22 07:55:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21463, encodeId=454821463f0, content=很漂亮啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=58.33.140.**, createdTime=Mon Apr 20 21:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21449, encodeId=9ac22144917, content=赞的, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.67.**, createdTime=Mon Apr 20 17:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=)]
    2015-04-20 58.33.140.**

    很漂亮啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1977246, encodeId=4b7719e72465c, content=<a href='/topic/show?id=f37214590b2' target=_blank style='color:#2F92EE;'>#PPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14590, encryptionId=f37214590b2, topicName=PPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Aug 11 13:55:00 CST 2015, time=2015-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861007, encodeId=7a53186100eda, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Sep 11 11:55:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621533, encodeId=e2c4162153301, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed Apr 22 07:55:00 CST 2015, time=2015-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21463, encodeId=454821463f0, content=很漂亮啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=58.33.140.**, createdTime=Mon Apr 20 21:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21449, encodeId=9ac22144917, content=赞的, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=101.81.67.**, createdTime=Mon Apr 20 17:12:00 CST 2015, time=2015-04-20, status=1, ipAttribution=)]
    2015-04-20 101.81.67.**

    赞的

    0

Baidu
map
Baidu
map
Baidu
map